Why insider trading matters?
What separates FormWhispers.com from others is that we created it to meet our own needs and we use it everyday to make better investment decisions. We will keep improving it to serve us better and to serve you better.
AxoGen, Inc., together with its subsidiaries, provides surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. AxoGen, Inc. is headquartered in Alachua, Florida.
| Trade Date | Insider | Title | Buy/Sell | #Shares | Price | Value | Option |
|---|---|---|---|---|---|---|---|
| 2021-08-10 | Zaderej Karen L. | CEO | Sell | 41,000 | $18.47 | $757,194 | Yes |
| 2021-02-25 | Freitag Gregory Gene | Director | Sell | 24,000 | $22.06 | $529,440 | No |
| 2021-02-18 | Donovan Michael Patrick | VP Operations | Sell | 1,808 | $19.15 | $34,623 | No |
| 2021-01-08 | Zaderej Karen L. | CEO | Sell | 65,000 | $20.00 | $1,300,000 | No |
| 2020-12-30 | Donovan Michael Patrick | VP Operations | Sell | 1,733 | $17.48 | $30,293 | No |
| 2020-12-29 | DeVinney Erick Wayne | VP, Clinical&Translational Sc | Sell | 371 | $17.81 | $6,608 | No |
| 2020-12-29 | Donovan Michael Patrick | VP Operations | Sell | 567 | $17.81 | $10,098 | No |
| 2020-12-29 | Freitag Gregory Gene | Director | Sell | 916 | $17.81 | $16,314 | No |
| 2020-12-29 | MARIANI PETER J | Chief Financial Officer | Sell | 1,293 | $17.81 | $23,028 | No |
| 2020-12-29 | Scopelianos Angelo | VP Research & Development | Sell | 567 | $17.81 | $10,098 | No |
| 2020-12-29 | Zaderej Karen L. | CEO | Sell | 3,500 | $17.81 | $62,335 | No |
| 2020-12-29 | Friedman Mark Louis | VP, Regulatory & Quality | Sell | 567 | $17.81 | $10,098 | No |
| 2020-12-29 | MARTINEZ MARIA D. | Chief Human Resources Officer | Sell | 567 | $17.81 | $10,098 | No |
| 2020-12-29 | Billet Isabelle | Chief Strategy and BD Officer | Sell | 649 | $17.81 | $11,559 | No |
| 2020-12-22 | Donovan Michael Patrick | VP Operations | Sell | 279 | $17.19 | $4,796 | No |
| 2020-12-21 | Zaderej Karen L. | CEO | Sell | 1,275 | $16.42 | $20,936 | No |
| 2020-12-21 | DeVinney Erick Wayne | VP, Clinical&Translational Sc | Sell | 147 | $16.42 | $2,414 | No |
| 2020-12-21 | Freitag Gregory Gene | Director | Sell | 379 | $16.42 | $6,223 | No |
| 2020-12-21 | Donovan Michael Patrick | VP Operations | Sell | 96 | $16.42 | $1,576 | No |
| 2020-12-21 | MARIANI PETER J | Chief Financial Officer | Sell | 481 | $16.42 | $7,898 | No |
| 2020-12-21 | Friedman Mark Louis | VP, Regulatory & Quality | Sell | 96 | $16.42 | $1,576 | No |
| 2020-11-09 | Donovan Michael Patrick | VP Operations | Sell | 17,617 | $15.00 | $264,255 | No |
| 2020-11-09 | Zaderej Karen L. | CEO | Sell | 14,000 | $14.53 | $203,420 | No |
| 2020-10-30 | MARIANI PETER J | Chief Financial Officer | Sell | 75,683 | $12.41 | $939,353 | Yes |
| 2019-08-12 | Blackford Quentin S. | Director | Buy | 15,535 | $14.01 | $217,672 | No |
| 2019-08-09 | Gold Mark Stephen | Director | Buy | 4,000 | $13.10 | $52,389 | No |
| 2019-08-13 | Billet Isabelle | Chief Strategy and BD Officer | Buy | 5,635 | $15.11 | $85,139 | No |
| 2019-08-14 | MARTINEZ MARIA D. | Chief Human Resources Officer | Buy | 2,000 | $15.13 | $30,260 | No |
| 2019-08-12 | Blackford Quentin S. | Director | Buy | 15,535 | $14.01 | $217,672 | No |
| 2019-08-09 | Zaderej Karen L. | CEO | Buy | 75,000 | $13.50 | $1,012,425 | No |
Insider Smart
Insider Smart